venBio Select Advisor

Avoro Capital Advisors as of Dec. 31, 2023

Portfolio Holdings for Avoro Capital Advisors

Avoro Capital Advisors holds 42 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Apellis Pharmaceuticals Common (APLS) 9.2 $665M 11M 59.86
United Therapeutics Corp Common (UTHR) 8.7 $629M 2.9M 219.89
Ascendis Pharma Sponsored ADR (ASND) 6.5 $473M 3.8M 125.95
Argenx Se Sponsored ADR (ARGX) 6.5 $470M 1.2M 380.43
Madrigal Pharmaceuticals Common (MDGL) 6.0 $437M 1.9M 231.38
Sarepta Therapeutics Common (SRPT) 5.8 $419M 4.3M 96.43
Biomarin Pharmaceutical Common (BMRN) 5.7 $415M 4.3M 96.42
Spdr Series Trust - S&p Biotech Etf (XBI) 5.5 $397M 4.4M 89.29
Amicus Therapeutics Common (FOLD) 5.4 $389M 27M 14.19
Cerevel Therapeutics Hldng Common (CERE) 4.4 $320M 7.6M 42.40
Krystal Biotech Common (KRYS) 4.4 $318M 2.6M 124.06
Mirati Therapeutics Common 4.0 $287M 4.9M 58.75
Cymabay Therapeutics Common 3.6 $262M 11M 23.62
Xenon Pharmaceuticals Common (XENE) 3.6 $261M 5.7M 46.06
Alnylam Pharmaceuticals Common (ALNY) 2.9 $213M 1.1M 191.41
Intra-cellular Therapies Common (ITCI) 2.2 $162M 2.3M 71.62
Moonlake Immunotherapeutics Class A Ord (MLTX) 2.2 $156M 2.6M 60.39
Kymera Therapeutics Common (KYMR) 1.3 $96M 3.8M 25.46
Structure Therapeutics Sponsored ADR (GPCR) 1.3 $95M 2.3M 40.76
Syndax Pharmaceuticals Common (SNDX) 1.3 $91M 4.2M 21.61
Biocryst Pharmaceuticals Common (BCRX) 1.1 $78M 13M 5.99
Iovance Biotherapeutics Common (IOVA) 0.8 $55M 6.7M 8.13
Roivant Sciences Common (ROIV) 0.7 $52M 4.7M 11.23
Kura Oncology Common (KURA) 0.6 $43M 3.0M 14.38
Spyre Therapeutics Common (SYRE) 0.5 $40M 1.8M 21.52
Karuna Therapeutics Common 0.5 $40M 125k 316.51
Rocket Pharmaceuticals Common (RCKT) 0.5 $38M 1.3M 29.97
Arrowhead Pharmaceuticals Common (ARWR) 0.5 $35M 1.1M 30.60
Marinus Pharmaceuticals Common 0.5 $34M 3.2M 10.87
Mannkind Corp Common (MNKD) 0.5 $33M 9.0M 3.64
Soleno Therapeutics Common (SLNO) 0.4 $32M 785k 40.25
Verrica Pharmaceuticals Common 0.4 $29M 4.0M 7.32
Immunogen Common 0.4 $26M 875k 29.65
Monte Rosa Therapeutics Common (GLUE) 0.4 $26M 4.5M 5.65
Merus N V Common (MRUS) 0.3 $24M 889k 27.50
Tourmaline Bio Common (TRML) 0.3 $23M 868k 26.18
Avidity Biosciences Common (RNA) 0.3 $23M 2.5M 9.05
Ultragenyx Pharmaceutical Common (RARE) 0.2 $17M 350k 47.82
Fennec Pharmaceuticals Common (FENC) 0.2 $14M 1.2M 11.22
Nuvalent Common (NUVL) 0.2 $13M 179k 73.59
Taysha Gene Therapies Common (TSHA) 0.1 $7.7M 4.4M 1.77
Aadi Biosciences Common (WHWK) 0.1 $5.8M 2.8M 2.02